Alzheimer's disease (AD) is an accelerating neurodegenerative disorder, dementia in the world. Current treatments for Alzheimer's disease primarily focus on enhancement of cholinergic transmission & leading to neuronal dysfunction and loss in the brain. Flavonoid bioactive compounds are the major role for the designer of a new generation of therapeutic agents that are clinically effective in treating neurodegenerative diseases. Apigenin & quercetin are attractive biomarkers in this regards which has been epidemiological studies height a Neuroprotective and related to a lower risk of developing dementia or gradual decline its progressive. The continuing investigation of the potential preventive activity of quercetin and apigenin should be evaluated in long-term exposure clinical trials, using preparations with high bioavailability and promising to yield a possible remedy for this pervasive disease. Thus, the aim of the review, we analyzed the enhancing effects of apigenin and quercetin and discuss the potential of these compounds for Alzheimer's disease prevention and treatment.
Introduction
Alzheimer's disease (AD) is one of the greatest widespread heterogeneous progressive neurodegenerative disorders of the central nervous system, dementia in the worldwide. Its pathological distinguishing attribute include synaptic degeneration, deposition of Aβ-containing senile plaques and phosphotau-containing tangles in brain. , which ultimately lead to neuronal dysfunction and loss in the brain 1, 2 . Dementia is a multifactorial syndrome that affects memory, thinking, language, behaviour and ability to perform everyday activities. According to the WHO Alzheimer Report today 3, 4 . dementia affects over 46 million people worldwide and this number is estimated to increase to 131.5 million by 2050 due to increased expectation of life and an aging population 5 .The most common form of dementia is Alzheimer disease (AD) that possibly contributes to 60%-70% of cases, with a greater proportion in the higher age ranges 6 . AD is a multifactorial disease with genetic (70%) and environmental (30%) causes. The familial early-onset form of AD is caused by mutations in genes APP (amyloid precursor protein), PSEN1 (Presenilin 1) and PSEN2 (Presenilin 2). The main factors of neurodegeneration are several cellular and molecular events such as oxidative stress, impaired mitochondrial function, and deposition of aggregated proteins, neuroinflammation, and activation of apoptotic factors 7, 8 .
Flavonoids are bioactive markers components that are derived from vegetables plants and fruits. Since ancient times, apigeninand quercetin rich nutraceuticals have been used as food supplements in improving cognitive function and in prevention of neurodegenerative diseases in humans 9 . Apigenin and quercetin rich flavonoids may be able to target multiple sites in the brain and prevent neurodegenerative diseases (Fig 1) .
Better animal models and good biomarkers for patient sub grouping will be also instrumental for quick advancement in the field 10 . The review revises all these aspects with the objective to generate debate among scientists. In this review, we emphasize the protective and preventive functions of apigenin and quercetin in neurodegenerative diseases by modulation of neurosignaling pathways 11, 12 . 13, 14 .
Neuroinflammation is also involved in the complex cascade leading to AD pathology and symptoms. It has been shown that AD is associated with increased levels of cyclooxygenase 1 and 2 and of prostaglandins, release of cytokines and chemokines, acute phase reaction, astrocytosis and microgliosis 15, 16 . These properties. However its contribution to neuroprotective mechanisms in human AD neurons is currently unknown 34, 35 . Quercetin (3,5,7,3′,4′-pentahydroxyflavone), the major flavonoid in the human diet, is widely found in fruits and vegetables, such as onions and apples, and red wine, has potential nutraceuticals and pharmaceutical uses 36 . These potential uses may be due to its high oxygen radical scavenging activity or its ability to inhibit xanthine oxidase and lipid peroxidation in vitro. 
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